{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:29:45Z","timestamp":1788492585864,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.steroids.2021.108822","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T16:37:17Z","timestamp":1615567037000},"page":"108822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Apoptosis inducing properties of 3-biotinylate-6-benzimidazole B-nor-cholesterol analogues"],"prefix":"10.1016","volume":"169","author":[{"given":"Zhiling","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2021.108822_b0005","series-title":"The Global Burden of Disease: 2004 Update","author":"Organization","year":"2008"},{"key":"10.1016\/j.steroids.2021.108822_b0010","doi-asserted-by":"crossref","first-page":"100670","DOI":"10.1016\/j.drup.2019.100670","article-title":"Phospholipids and cholesterol: inducers of cancer multidrug resistance and therapeutic targets","volume":"49","author":"Kopecka","year":"2020","journal-title":"Drug. Resist. Updat."},{"issue":"10","key":"10.1016\/j.steroids.2021.108822_b0015","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1016\/j.ejmech.2009.04.020","article-title":"Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents","volume":"44","author":"El-Far","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2021.108822_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2017.12.094","article-title":"Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents","volume":"145","author":"Shi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2021.108822_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.09.038","article-title":"Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer","volume":"105","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2021.108822_b0030","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/12081859","article-title":"Exploitation of bile acid transport systems in prodrug design","volume":"12","author":"Siev\u00e4nen","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.steroids.2021.108822_b0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/BST20150232","article-title":"When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1","volume":"44","author":"Poirot","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.steroids.2021.108822_b0040","doi-asserted-by":"crossref","first-page":"105371","DOI":"10.1016\/j.jsbmb.2019.04.020","article-title":"Induction of a non-apoptotic mode of cell death associated with autophagic characteristics with steroidal maleic anhydrides and 7\u03b2-hydroxycholesterol on glioma cells","volume":"191","author":"Sassi","year":"2019","journal-title":"J. Steroid Biochem. Mol. Bio."},{"issue":"36","key":"10.1016\/j.steroids.2021.108822_b0045","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1016\/S0040-4039(01)01278-3","article-title":"Orostanal, a novel abeo-sterol inducing apoptosis in leukemia cell from a marine sponge, Stelletta hiwasaensis","volume":"42","author":"Miyamoto","year":"2001","journal-title":"Tetrahedron. Lett."},{"issue":"50","key":"10.1016\/j.steroids.2021.108822_b0050","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1016\/j.tetlet.2007.10.070","article-title":"Novel ring B abeo-sterols as growth inhibitors of Mycobacterium tuberculosis isolated from a Caribbean Sea sponge, Svenzea zeai","volume":"48","author":"Wei","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.steroids.2021.108822_b0055","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2174\/1573406411309060008","article-title":"Synthesis of novel ring B Abeo-sterol derivatives and their antiproliferative activities","volume":"9","author":"Gan","year":"2013","journal-title":"Med. Chem."},{"issue":"11","key":"10.1016\/j.steroids.2021.108822_b0060","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.steroids.2012.05.005","article-title":"Synthesis and in vitro antiproliferative evaluation of some ring B abeo-sterols","volume":"77","author":"Gan","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2021.108822_b0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.steroids.2013.10.009","article-title":"Synthesis and in vitro antiproliferative evaluation of some novel B-norcholesterols","volume":"79","author":"Gan","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2021.108822_b0070","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3390\/md13042488","article-title":"Synthesis and in vitro antiproliferative evaluation of some B-norcholesteryl benzimidazole and benzothiazole derivatives","volume":"13","author":"Cui","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.steroids.2021.108822_b0075","doi-asserted-by":"crossref","first-page":"105709","DOI":"10.1016\/j.jsbmb.2020.105709","article-title":"Untargeted metabolomics study and pro-apoptotic properties of B-norcholesteryl benzimidazole compounds in ovarian cancer SKOV3 cells","volume":"202","author":"Gan","year":"2020","journal-title":"J. Steroid Biochem. Mol. Bio."},{"issue":"9","key":"10.1016\/j.steroids.2021.108822_b0080","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s00044-016-1614-y","article-title":"Syntheses, in vitro evaluation and molecular docking studies of 5-bromo-2-aryl benzimidazoles as\u03b1-glucosidase inhibitors","volume":"25","author":"Arshad","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.steroids.2021.108822_b0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejmech.2013.03.010","article-title":"Design, synthesis and antiproliferative properties of some new 5-substituted-2-iminobenzimidazole derivatives","volume":"63","author":"Mavrova","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2021.108822_b0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molstruc.2011.10.054","article-title":"Synthesis, crystal structure determination and antiproliferative activity of novel 2-amino-4-aryl-4,10-dihydro[1,3,5]triazino[1,2-a]benzimidazoles","volume":"1007","author":"Hranjec","year":"2012","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.steroids.2021.108822_b0095","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/la000498i","article-title":"Vesicle formation from oligo(oxyethylene)-bearing cholesteryl amphiphiles: site-selective effects of oxyethylene units on the membrane order and thickness","volume":"17","author":"Bhattacharya","year":"2001","journal-title":"Langmuir"},{"key":"10.1016\/j.steroids.2021.108822_b0100","doi-asserted-by":"crossref","unstructured":"J.F.R. Kerr, G.C. Gob\u00e9, C.M. Winterford, B.V. Harmon, Methods in Cell Biology, Elsevier, 1995. https:\/\/doi.org\/10.1016\/S0091-679X(08)61921-4.","DOI":"10.1016\/S0091-679X(08)61921-4"},{"key":"10.1016\/j.steroids.2021.108822_b0105","first-page":"573","article-title":"Why target apoptosis in cancer treatment?","volume":"2","author":"Kasibhatla","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.steroids.2021.108822_b0110","doi-asserted-by":"crossref","unstructured":"H.M. Shapiro, Overture - Practical Flow Cytometry, John Wiley & Sons, 2003. https:\/\/doi.org\/10.1002\/0471722731.ch1.","DOI":"10.1002\/0471722731.ch1"},{"issue":"5192","key":"10.1016\/j.steroids.2021.108822_b0115","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1126\/science.7997877","article-title":"Cell cycle control and cancer","volume":"266","author":"Hartwell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.steroids.2021.108822_b0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1083\/jcb.66.1.188","article-title":"Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining","volume":"66","author":"Krishan","year":"1975","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.steroids.2021.108822_b0125","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2018.04.009","article-title":"Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties","volume":"151","author":"Hu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.steroids.2021.108822_b0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.10699","article-title":"Cell cycle checkpoints and their impact on anticancer therapeutic strategies","volume":"91","author":"Eastman","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.steroids.2021.108822_b0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10495-012-0797-z","article-title":"hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells","volume":"18","author":"Lei","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.steroids.2021.108822_b0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"Cell cycle regulators and beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev. Cell."},{"key":"10.1016\/j.steroids.2021.108822_b0145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2021.108822_b0150","unstructured":"A.L. Gartel, A.L. Tyner, The role of the cyclin-dependent kinase inhibitor p21 in apoptosis 1 supported in part by NIH grant R01 DK56283 (to A. L. T.) for the p21 research and Campus Research Board and Illinois Department of Public Health Penny severns breast and cervical cancer grants (to A. L. G.).1, Mol. Cancer. Ther. 1(8) (2002) 639\u2013649. https:\/\/mct.aacrjournals.org\/content\/1\/8\/639.long."},{"issue":"5200","key":"10.1016\/j.steroids.2021.108822_b0155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7863329","article-title":"p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells","volume":"267","author":"Parker","year":"1995","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.steroids.2021.108822_b0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.steroids.2021.108822_b0165","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1002\/jcb.23296","article-title":"Protein and its function based on a subcellular localization","volume":"112","author":"\u0106mielov\u00e1","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.steroids.2021.108822_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(01)00847-3","article-title":"Oncogenic functions of tumour suppressor p21(Waf1\/Cip1\/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts","volume":"179","author":"Roninson","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.steroids.2021.108822_b0175","first-page":"2922","article-title":"The expanding role of mitochondria in apoptosis","volume":"15","author":"Wang","year":"2001","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.steroids.2021.108822_b0180","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.jmedchem.6b01652","article-title":"A novel potent anticancer compound optimized from a natural oridonin scaffold induces apoptosis and cell cycle arrest through the mitochondrial pathway","volume":"60","author":"Xu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2021.108822_b0185","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejmech.2017.04.045","article-title":"Discovery of novel antitumor nitric oxide-donating \u03b2 -elemene hybrids through inhibiting the PI3K\/Akt pathway","volume":"135","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2021.108822_b0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejmech.2018.02.088","article-title":"Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: design, synthesis and antitumor biological evaluation","volume":"150","author":"Han","year":"2018","journal-title":"Eur. J. Med. Chem."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X21000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X21000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:05:42Z","timestamp":1758535542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X21000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"alternative-id":["S0039128X21000349"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2021.108822","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apoptosis inducing properties of 3-biotinylate-6-benzimidazole B-nor-cholesterol analogues","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2021.108822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108822"}}